Dhanuka Agritech Limited — Q1FY27 earnings call summary

Filed 03 August 2026 · Company audio recording

FY27 revenue declined 12.56% YoY to Rs. 462 cr due to delayed monsoon and weak demand; single-digit growth expected for full year.
Pricing power limited; attempted price hikes in June were reversed due to weak demand and competition.
New biological and nutrition products gaining traction; three biological launches expected by August.
Market share shifts expected as smaller/unorganized players face regulatory challenges in biostimulants.
Nagpur formulation plant (23,000 MT capacity) to be operational by April 2028 with Rs. 200 cr capex, aiming for automation and scalability.
Dahej technical synthesis plant revenue up to Rs. 26 cr in Q1 FY27; EBITDA still negative, breakeven unlikely this year.
Operating expenses flat QoQ despite 12% revenue decline, reflecting fixed costs and seasonally planned spends.
Q2 and Q3 expected to see better momentum but remain challenging due to uneven rainfall.